Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma

Author: Wu Jennifer   Henderson Charles   Feun Lynn   Veldhuizen Peter   Gold Philip   Zheng Hui   Ryan Theresa   Blaszkowsky Lawrence   Chen HaoBin   Costa Max   Rosenzweig Barry   Nierodzik MaryLynn   Hochster Howard   Muggia Franco   Abbadessa Giovanni   Lewis Jonathan   Zhu Andrew  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.28, Iss.5, 2010-10, pp. : 670-676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content